[HTML] thelancet.com

[HTML][HTML] Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet Infectious …, 2023 - thelancet.com
Vaccination represents the key strategy to control the COVID-19 pandemic through induction
of neutralising antibody responses and T cellassociated immunitythat substantially decrease …
被引用次数：126 相关文章

Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies Omicron sublineage BQ.1.1
resistance to monoclonal antibodies Lancet Infect Dis. 2023 Jan;23(1):22-23. doi: 10.1016/S1473-3099(22)00733-2 …

[引用][C] Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, SR Schulz… - 2022 - publications.goettingen-research …

Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, S Schulz… - The Lancet. Infectious …, 2022 - europepmc.org
Vaccination represents the key strategy to control the COVID-19 pandemic through induction
of neutralising antibody responses and T cellassociated immunitythat substantially decrease …

Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies.

P Arora, A Kempf, I Nehlmeier, SR Schulz, HM Jäck… - 2022 - cabidigitallibrary.org
This study aimed to compare the efficacy of various monoclonal antibodies (mAbs) or mAb
cocktails in neutralizing different sublineages of the Omicron variant of SARS-CoV-2 …
[HTML] thelancet.com

[HTML][HTML] Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet Infectious …, 2023 - thelancet.com
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies - The Lancet Infectious
Diseases Skip to Main Content Advertisement The Lancet Infectious Diseases Submit Article …
[HTML] nih.gov

[HTML][HTML] Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet. Infectious …, 2023 - ncbi.nlm.nih.gov
Vaccination represents the key strategy to control the COVID-19 pandemic through induction
of neutralising antibody responses and T cellassociated immunitythat substantially decrease …

[引用][C] Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier, SR Schulz… - 2023 - publications.goettingen-research …

Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies

P Arora, A Kempf, I Nehlmeier… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies Omicron sublineage BQ.1.1
resistance to monoclonal antibodies Lancet Infect Dis. 2023 Jan;23(1):22-23. doi: 10.1016/S1473-3099(22)00733-2 …

[引用][C] Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies.

P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet. Infectious …, 2022 - europepmc.org